Search scope:
排序: Display mode:
Improved dissolution and anti-inflammatory effect of ibuprofen by solid dispersion
Liyuan Chen, Qifeng Dang, Chengsheng Liu, Jun Chen, Lei Song, Xiguang Chen
Frontiers of Medicine 2012, Volume 6, Issue 2, Pages 195-203 doi: 10.1007/s11684-012-0189-3
The purpose of this study was to improve the dissolution rate and anti-inflammatory effect of ibuprofenThe anti-inflammatory effect of SDBT was evaluated using the mouse ear edema test with xylene.SDBT displayed more significant anti-inflammatory effects than CT.The dissolution rate and anti-inflammatory effect of ibuprofen were significantly enhanced by the ibuprofen-urea
Keywords: ibuprofen solid dispersion physical mixture dissolution anti-inflammatory effect
Jianping Ye
Frontiers of Medicine 2015, Volume 9, Issue 2, Pages 139-145 doi: 10.1007/s11684-015-0377-z
Keywords: inflammation obesity cytokine energy expenditure insulin resistance
Na You, Sasa Chu, Binggang Cai, Youfang Gao, Mizhou Hui, Jin Zhu, Maorong Wang
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 292-301 doi: 10.1007/s11684-020-0806-5
Keywords: bioactive hyaluronan lipopolysaccharide inflammatory cytokines TLR4 human macrophages
Non-genetic mechanisms of diabetic nephropathy
Qiuxia Han, Hanyu Zhu, Xiangmei Chen, Zhangsuo Liu
Frontiers of Medicine 2017, Volume 11, Issue 3, Pages 319-332 doi: 10.1007/s11684-017-0569-9
Diabetic nephropathy (DN) is one of the most common microvascular complications in diabetes mellitus patients and is characterized by thickened glomerular basement membrane, increased extracellular matrix formation, and podocyte loss. These phenomena lead to proteinuria and altered glomerular filtration rate, that is, the rate initially increases but progressively decreases. DN has become the leading cause of end-stage renal disease. Its prevalence shows a rapid growth trend and causes heavy social and economic burden in many countries. However, this disease is multifactorial, and its mechanism is poorly understood due to the complex pathogenesis of DN. In this review, we highlight the new molecular insights about the pathogenesis of DN from the aspects of immune inflammation response, epithelial–mesenchymal transition, apoptosis and mitochondrial damage, epigenetics, and podocyte–endothelial communication. This work offers groundwork for understanding the initiation and progression of DN, as well as provides ideas for developing new prevention and treatment measures.
Keywords: diabetic nephropathy immune inflammatory response epithelial–mesenchymal transition apoptosis mitochondrial
Metformin and metabolic diseases: a focus on hepatic aspects
Juan Zheng,Shih-Lung Woo,Xiang Hu,Rachel Botchlett,Lulu Chen,Yuqing Huo,Chaodong Wu
Frontiers of Medicine 2015, Volume 9, Issue 2, Pages 173-186 doi: 10.1007/s11684-015-0384-0
Metformin has been widely used as a first-line anti-diabetic medicine for the treatment of type 2 diabetes (T2D). As a drug that primarily targets the liver, metformin suppresses hepatic glucose production (HGP), serving as the main mechanism by which metformin improves hyperglycemia of T2D. Biochemically, metformin suppresses gluconeogenesis and stimulates glycolysis. Metformin also inhibits glycogenolysis, which is a pathway that critically contributes to elevated HGP. While generating beneficial effects on hyperglycemia, metformin also improves insulin resistance and corrects dyslipidemia in patients with T2D. These beneficial effects of metformin implicate a role for metformin in managing non-alcoholic fatty liver disease. As supported by the results from both human and animal studies, metformin improves hepatic steatosis and suppresses liver inflammation. Mechanistically, the beneficial effects of metformin on hepatic aspects are mediated through both adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. In addition, metformin is generally safe and may also benefit patients with other chronic liver diseases.
Keywords: metformin diabetes hepatic steatosis inflammatory response insulin resistance
Wu Xiaojie,Liu Xia,Tao Yueping,Wang Jie
Strategic Study of CAE 2015, Volume 17, Issue 6, Pages 4-7
Keywords: levonorgestrel Intrauterine system insulin-like growth factor-1 pelvic inflammatory disease
Intestinal Epithelial Axin1 Deficiency Protects Against Colitis via Altered Gut Microbiota
Shari Garrett,Yongguo Zhang,Yinglin Xia,Jun Sun,
Engineering doi: 10.1016/j.eng.2023.06.007
Keywords: Axin1 Bacteria Microbiome inflammation Inflammatory bowel disease Immunity Microbiome Paneth cells Akkermansia
Recent advances in myeloid-derived suppressor cell biology
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani, Ammar Daoud
Frontiers of Medicine 2021, Volume 15, Issue 2, Pages 232-251 doi: 10.1007/s11684-020-0797-2
Keywords: non-human primates (rhesus macaques) myeloid-derived pro-inflammatory cells (MDPCs) autoimmune disorders
Effect of IL-10 on formation of foam cell induced by ox-LDL
WANG Fei, DAI Yalei, XU Ting, XU Bo, WANG Kaifeng
Frontiers of Medicine 2008, Volume 2, Issue 3, Pages 298-302 doi: 10.1007/s11684-008-0057-3
Keywords: inflammatory presence interleukin-10 dose-dependent ox-LDL
Keratin 5-Cre-driven deletion of
Jun Yang, Lianqing Wang, Yingzhi Huang, Keqiang Liu, Chaoxia Lu, Nuo Si, Rongrong Wang, Yaping Liu, Xue Zhang
Frontiers of Medicine 2020, Volume 14, Issue 3, Pages 305-317 doi: 10.1007/s11684-019-0722-8
Keywords: acne inversa mouse model interleukin 1 family member 6 small proline rich protein 2D key inflammatory
Research about bacteriology on intrauterine device
Zhang Xianghui,Qu Wenwen,Huang Wei,Fang Jie,Wu Fanzi,Zhou Xinxuan
Strategic Study of CAE 2015, Volume 17, Issue 6, Pages 21-27
Keywords: intrauterine device pelvic inflammatory disease bacterial biofilm scanning electron microscopy
Yan Zhao, Chengcheng Zhang, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Wei Chen, Qixiao Zhai
Engineering 2022, Volume 17, Issue 10, Pages 170-182 doi: 10.1016/j.eng.2020.09.016
•Some specific genes may account for the anti-inflammatory and immunoregulation of of the phylogenetic tree and strain type L. fermentum CECT5716 were selected and their anti-inflammatoryThe anti-inflammatory mechanisms of L. fermentum FXJCJ61 and CECT5716 were related to the inhibitionComparative genomic analysis of these strains identified candidate genes that may contribute to the anti-inflammatory
Keywords: Lactobacillus fermentum Ulcerative colitis Anti-inflammation Phylogenetic analysis Comparative genomic analysis
Ying Shi, Hu-Dan Pan, Jian-Lin Wu, Qing-Hua Zou, Xin-Yi Xie, Hong-Gang Li, Hua Zhou, Xi-Qing Bian, Wen-Fei Leng, Can-Jian Wang, Ya-Feng Wang, Yong-Fei Fang, Liang Liu
Engineering 2022, Volume 16, Issue 9, Pages 93-99 doi: 10.1016/j.eng.2021.04.014
Sinomenine (SIN) is commonly used as part of rheumatoid arthritis (RA) therapy in China, but there is still no published evidence of the efficacy of SIN monotherapy. This work investigates the efficacy and safety of SIN in treating RA patients and analyzes the correlation between ornithine level and the alleviation of disease activity in RA patients. In this 24 week, randomized, placebo-controlled, double-blind clinical trial, people with mild to moderate RA were randomly assigned (1:1:1, stratified by hospital) to receive SIN (120 mg, twice daily), methotrexate (MTX) (10 mg per week), or SIN + MTX therapy. The primary outcome was the proportion of patients who achieved a 50% improvement in the American College of Rheumatology (ACR) criteria at week 24 and who showed improvement according to the clinical disease activity index (CDAI). In this prospective subgroup analysis, we also assessed whether the 24 week alterations of disease activity in the treatment group were significantly correlated to the levels of blood ornithine. Of the 135 enrolled participants, 38, 39, and 36 patients were treated with SIN, MTX, and SIN + MTX, respectively. In the SIN-treated group, 52.63% of patients achieved ACR50 after 24 weeks of treatment, which was comparable to the results in the MTX-treated and SIN + MTX-treated groups. Hepatic and gastrointestinal disorders were the main adverse events; however, the ratio of patients suffering from hepatic disorder in the SIN group (1/38) was much lower than that in the MTX (10/39) and SIN + MTX (8/36) groups. A total of 221 serum samples were collected at the four follow-up time points in the three treatments, and the levels of ornithine, citrulline, and arginine were obtained through ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF/MS). The serum ornithine level decreased after the 24 week treatment along with a decrease in disease activity, and may reflect therapeutic responses with a sensitivity value of 80%. In conclusion, SIN revealed a comparable efficacy to MTX for treating RA patients, but with fewer side effects. In addition, the serum ornithine level was found for the first time to have a close correlation with the alleviation of RA, which shows the value of this measure as an assessment indicator of drugs in treating RA.
Keywords: Rheumatoid arthritis Sinomenine Efficacy Safety Inflammatory biomarker
Title Author Date Type Operation
Improved dissolution and anti-inflammatory effect of ibuprofen by solid dispersion
Liyuan Chen, Qifeng Dang, Chengsheng Liu, Jun Chen, Lei Song, Xiguang Chen
Journal Article
Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes
Jianping Ye
Journal Article
Bioactive hyaluronic acid fragments inhibit lipopolysaccharide-induced inflammatory responses via the
Na You, Sasa Chu, Binggang Cai, Youfang Gao, Mizhou Hui, Jin Zhu, Maorong Wang
Journal Article
Non-genetic mechanisms of diabetic nephropathy
Qiuxia Han, Hanyu Zhu, Xiangmei Chen, Zhangsuo Liu
Journal Article
Metformin and metabolic diseases: a focus on hepatic aspects
Juan Zheng,Shih-Lung Woo,Xiang Hu,Rachel Botchlett,Lulu Chen,Yuqing Huo,Chaodong Wu
Journal Article
Effect of levonorgestrel intrauterine system on IGF-1 and the dependablity study of prevention pelvic inflammatory
Wu Xiaojie,Liu Xia,Tao Yueping,Wang Jie
Journal Article
Intestinal Epithelial Axin1 Deficiency Protects Against Colitis via Altered Gut Microbiota
Shari Garrett,Yongguo Zhang,Yinglin Xia,Jun Sun,
Journal Article
Recent advances in myeloid-derived suppressor cell biology
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani, Ammar Daoud
Journal Article
Effect of IL-10 on formation of foam cell induced by ox-LDL
WANG Fei, DAI Yalei, XU Ting, XU Bo, WANG Kaifeng
Journal Article
Keratin 5-Cre-driven deletion of
Jun Yang, Lianqing Wang, Yingzhi Huang, Keqiang Liu, Chaoxia Lu, Nuo Si, Rongrong Wang, Yaping Liu, Xue Zhang
Journal Article
Research about bacteriology on intrauterine device
Zhang Xianghui,Qu Wenwen,Huang Wei,Fang Jie,Wu Fanzi,Zhou Xinxuan
Journal Article
Analysis of Lactobacillus fermentum Strains and the Key Genes Related to Their Intestinal Anti-inflammatory
Yan Zhao, Chengcheng Zhang, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Wei Chen, Qixiao Zhai
Journal Article
The Correlation Between Decreased Ornithine Level and Alleviation of Rheumatoid Arthritis Patients Assessed by a Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Sinomenine
Ying Shi, Hu-Dan Pan, Jian-Lin Wu, Qing-Hua Zou, Xin-Yi Xie, Hong-Gang Li, Hua Zhou, Xi-Qing Bian, Wen-Fei Leng, Can-Jian Wang, Ya-Feng Wang, Yong-Fei Fang, Liang Liu
Journal Article